XML 35 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Deferred Revenue (Details) (USD $)
1 Months Ended
Jul. 31, 2013
May 30, 2013
Apr. 30, 2013
Jul. 17, 2013
Apr. 16, 2013
Deferred Revenue [Abstract]          
Funding for the research, development, marketing and commercialization of a product   $ 150,000     $ 600,000
Percentage of net profit generated from the product in perpetuity   1.50%   5.00% 6.00%
Marketing term limit 24 months 24 months 24 months    
Options exercise period 60 days 60 days 60 days    
Potential shares in lieu of the interest in the product 6,250,000 1,875,000 7,500,000